Unnamed: 0,title,date,stock,sentiment
1052060.0,"The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid",2020-06-05 07:34:00-04:00,QGEN,positive
1052061.0,"The Daily Biotech Pulse: Positive Readout For Kezar, AstraZeneca Stitches Oncology Partnership, D-Day For Merck's Triple Combo Antibiotic",2020-06-04 08:13:00-04:00,QGEN,positive
1052062.0,"The Daily Biotech Pulse: Regulatory Delay For Novartis' Multiple Sclerosis Drug, FSD Gets Nod For COVID-19 Study",2020-06-03 07:39:00-04:00,QGEN,negative
1052063.0,Stocks That Hit 52-Week Highs On Tuesday,2020-06-02 10:33:00-04:00,QGEN,neutral
1052064.0,Stocks That Hit 52-Week Highs On Friday,2020-05-29 10:36:00-04:00,QGEN,neutral
1052065.0,"The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant",2020-05-29 07:22:00-04:00,QGEN,positive
1052066.0,Stocks That Hit 52-Week Highs On Thursday,2020-05-28 10:39:00-04:00,QGEN,neutral
1052067.0,"The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas",2020-05-27 07:25:00-04:00,QGEN,positive
1052068.0,"The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive",2020-05-21 08:01:00-04:00,QGEN,neutral
1052069.0,"The Daily Biotech Pulse: NASH Disappointment For Genfit, Novavax Lands $384M CEPI Funding For Coronavirus Vaccine, GW Pharma Earnings",2020-05-12 08:06:00-04:00,QGEN,negative
1052070.0,"Qiagen Q1 EPS $0.340 Beats $0.270 Estimate, Sales $372.100M Beat $344.870M Estimate",2020-05-06 16:37:00-04:00,QGEN,neutral
1052071.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,QGEN,positive
1052072.0,"UPDATE: QIAGEN Sees Q2 Net Sales Up At Least 12%, Adj. EPS At Least $0.40",2020-05-05 16:56:00-04:00,QGEN,neutral
1052073.0,QIAGEN Sees Q2 Results Higher Than Previously Expected; Suspends FY20 Guidance,2020-05-05 16:55:00-04:00,QGEN,neutral
1052074.0,The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace,2020-05-03 08:45:00-04:00,QGEN,neutral
1052075.0,Pentagon Officials Don't Expect to Have Enough Tests for All Service Members Until Sometime This Summer,2020-04-26 09:00:00-04:00,QGEN,neutral
1052076.0,Qiagen Option Alert: May 15 $43 Calls Sweep (22) near the Ask: 451 @ $0.801 vs 264 OI; Earnings 5/4 After Close [est] Ref=$42.05,2020-04-22 13:07:00-04:00,QGEN,positive
1052077.0,Qiagen Option Alert: May 15 $42 Calls at the Ask: 3990 @ $0.451 vs 594 OI; Earnings 5/4 After Close [est] Ref=$40.535,2020-04-17 15:31:00-04:00,QGEN,positive
1052078.0,QIAGEN Receives FDA Approval For Therascreen BRAF V600E RGQ PCR Assay As Companion Diagnostic,2020-04-15 16:07:00-04:00,QGEN,positive
1052079.0,UPS Speeds Up Delivery Of Qiagen Coronavirus Test Kits,2020-04-14 15:52:00-04:00,QGEN,neutral
1052080.0,UPS Expedites Global Deliveries Of QIAGEN Coronavirus Testing Kits,2020-04-14 05:29:00-04:00,QGEN,neutral
1052081.0,QIAGEN Sees Q1 Adj. EPS $0.34-$0.35 vs $0.28 Estimate,2020-04-09 12:32:00-04:00,QGEN,neutral
1052082.0,"Stifel Maintains Hold on Qiagen, Raises Price Target to $40",2020-04-02 11:32:00-04:00,QGEN,neutral
1052083.0,Shares of several healthcare companies are trading lower amid market weakness as growing coronavirus concerns in the US weigh on equities.,2020-04-01 09:20:00-04:00,QGEN,negative
1052084.0,QIAGEN Earlier Receives U.S. FDA EUA For QIAstat-Dx Test Kit,2020-03-31 10:54:00-04:00,QGEN,neutral
1052085.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger",2020-03-26 08:23:00-04:00,QGEN,negative
1052086.0,QIAGEN Names Thierry Bernard CEO,2020-03-24 13:00:00-04:00,QGEN,neutral
1052087.0,"The Daily Biotech Pulse: Milestone Pharma Flunks Late-Stage Study, CytomX Strikes Cancer Drug Collaboration, BARDA Grant For GenMark's COVID-19 Test",2020-03-24 08:20:00-04:00,QGEN,negative
1052088.0,QIAGEN Releases QIAstat-Dx Test Kit to the U.S. as First Syndromic Test for Detection of SARS-CoV-2 Coronavirus Under New FDA Policy,2020-03-24 05:32:00-04:00,QGEN,neutral
1052089.0,"VP Pence Says One in Ten Americans Who Were Tested for the Coronavirus, Tested Positive",2020-03-22 18:31:00-04:00,QGEN,positive
1052090.0,QIAGEN Earlier Launches QIAstat-Dx Test Kit For Detection Of SARS-CoV-2 Coronavirus In Europe Following CE Marking,2020-03-19 09:22:00-04:00,QGEN,neutral
1052091.0,"The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",2020-03-19 07:37:00-04:00,QGEN,neutral
1052092.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,QGEN,positive
1052093.0,QIAGEN Reports Dramatic Ramp Of Global Production Capacity For RNA Extraction Kits For Coronavirus,2020-03-17 16:09:00-04:00,QGEN,neutral
1052094.0,Qiagen Says Ramping Up Global Production Capacity For RNA Extraction Kits For Use In Detection Of Coronavirus,2020-03-17 15:43:00-04:00,QGEN,neutral
1052095.0,18 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-17 08:58:00-04:00,QGEN,neutral
1052096.0,"VOA Reporter Steve Herman Tweet: ""We have a surplus capacity already of tests that have been produced,"" says @SecAzar",2020-03-10 18:17:00-04:00,QGEN,neutral
1052097.0,Shares of several healthcare companies are trading higher as markets rebound following Monday's selloff. US President Trump on Monday indicated the US may implement payroll tax cuts and other measures to support the economy amid the coronavirus outbreak.,2020-03-10 07:54:00-04:00,QGEN,positive
1052098.0,"CFRA Maintains Hold on Qiagen, Raises Price Target to $42",2020-03-06 10:57:00-05:00,QGEN,neutral
1052099.0,85 Biggest Movers From Yesterday,2020-03-04 05:04:00-05:00,QGEN,neutral
1052100.0,50 Stocks Moving In Tuesday's Mid-Day Session,2020-03-03 12:03:00-05:00,QGEN,neutral
1052101.0,Thermo Fisher To Buy Qiagen For $11.5B,2020-03-03 08:27:00-05:00,QGEN,neutral
1052102.0,Qiagen shares are trading higher after Thermo Fisher announced it will acquire the company for €39 per share in cash.,2020-03-03 08:15:00-05:00,QGEN,positive
1052103.0,40 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-03 08:10:00-05:00,QGEN,neutral
1052104.0,"The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More",2020-03-03 07:51:00-05:00,QGEN,positive
1052105.0,40 Stocks Moving in Tuesday's Pre-Market Session,2020-03-03 07:31:00-05:00,QGEN,neutral
1052106.0,"UPDATE: Thermo Fisher Reports Co., QIAGEN Boards Approved Deal For Co. At €39/Share In Cash",2020-03-03 07:02:00-05:00,QGEN,positive
1052107.0,Thermo Fisher Reports Purchase Of QIAGEN In $11.5B Deal,2020-03-03 07:01:00-05:00,QGEN,neutral
1052108.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,2020-03-03 06:02:00-05:00,QGEN,neutral
1052109.0,Thermo Fisher Scientific to Acquire QIAGEN for €39/Share in Cash,2020-03-03 05:07:00-05:00,QGEN,neutral
1052110.0,Atlanta Lab for Coronavirus Test Kits May have been Contaminated,2020-03-01 18:30:00-05:00,QGEN,neutral
1052111.0,"Health Secretary Azar Says 75,000 Diagnostic Kits Available to Test for Coronavirus, Number to Expand Radically",2020-03-01 09:41:00-05:00,QGEN,positive
1052112.0,FDA Issues New Policy to Help Expedite Availability of Diagnostics,2020-03-01 08:17:00-05:00,QGEN,positive
1052113.0,Qiagen To Submit COVID-19 Test Panel To FDA By Monday At Latest,2020-02-27 14:41:00-05:00,QGEN,neutral
1052114.0,Qiagen shares are trading higher after the company announced it has delivered its new QIAstat-Dx Respiratory Panel 2019-nCoV test kit to four hospitals in China for evaluation.,2020-02-27 07:55:00-05:00,QGEN,positive
1052115.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-27 07:40:00-05:00,QGEN,neutral
1052116.0,QIAGEN Announces Worldwide Shipments Of QIAstat-Dx Test Kits For SARS-CoV-2,2020-02-26 16:00:00-05:00,QGEN,neutral
1052117.0,Hearing M&A Blog Out Saying Qiagen Has Received 'Numerous Bids' And Remains a 'Motivated Seller'; Unconfirmed,2020-02-06 13:23:00-05:00,QGEN,positive
1052118.0,"CFRA Maintains Hold on Qiagen, Lowers Price Target to $38",2020-02-06 10:42:00-05:00,QGEN,negative
1052119.0,90 Biggest Movers From Yesterday,2020-02-06 05:15:00-05:00,QGEN,neutral
1052120.0,68 Stocks Moving In Wednesday's Mid-Day Session,2020-02-05 12:16:00-05:00,QGEN,neutral
1052121.0,"From Qiagen Earnings Conference Call: CFO Says Co. 'Extremely Active' In Providing Institutions In China With Tests, Consumables, Working On Cornavirus Testing Solutions",2020-02-05 09:44:00-05:00,QGEN,positive
1052122.0,Qiagen shares are trading higher after the company reported better-than-expected Q4 EPS and sales results.,2020-02-05 08:35:00-05:00,QGEN,positive
1052123.0,8 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-02-05 07:43:00-05:00,QGEN,neutral
1052124.0,"The Daily Biotech Pulse: Merck Spins Off Slow-Growth Businesses, ZioPharm Announces Offering, PhaseBio Data",2020-02-05 07:43:00-05:00,QGEN,neutral
1052125.0,36 Stocks Moving in Wednesday's Pre-Market Session,2020-02-05 07:23:00-05:00,QGEN,neutral
1052126.0,"Qiagen NV Q4 EPS $0.48 Beats $0.44 Estimate, Sales $413.5M Beat $408.58M Estimate",2020-02-04 16:12:00-05:00,QGEN,neutral
1052127.0,"The Daily Biotech Pulse: EyePoint In-Licenses Eye Disorder Drug, BioMarin CFO Quits, Rockwell Medical To Offer Shares",2020-02-04 07:51:00-05:00,QGEN,negative
1052128.0,"Earnings Scheduled For February 4, 2020",2020-02-04 04:21:00-05:00,QGEN,neutral
1052129.0,QIAGEN Launches FFPE And Liquid Biopsy PIK3CA Diagnostics In Europe To Enhance Precision Medicine In Advanced Breast Cancer,2020-02-03 16:08:00-05:00,QGEN,negative
1052130.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,QGEN,neutral
1052131.0,Qiagen Option Alert: Fri $35 Calls Sweep (41) near the Ask: 534 @ $0.65 vs 14482 OI; Earnings 2/4 After Close Ref=$35.69,2020-01-17 15:10:00-05:00,QGEN,positive
1052132.0,"Qiagen Shares Spike, Hearing CTFN Reports Co. Is In Late Stage Talks To Be Acquired; Unconfirmed",2020-01-17 14:51:00-05:00,QGEN,positive
1052133.0,"The Daily Biotech Pulse: PhaseBio To Buy Hypertension Asset, Stemline Falls On Q4 Pre-Announcement, FDA Panel To Review Nektar's Opioid Drug",2020-01-14 07:55:00-05:00,QGEN,positive
1052134.0,Qiagen Builds On Global Collaboration With Amgen For Companion Diagnostic Development In Non-small Cell Lung Cancer,2020-01-13 16:07:00-05:00,QGEN,negative
1052135.0,"UBS Maintains Neutral on Qiagen, Lowers Price Target to $36",2020-01-10 10:43:00-05:00,QGEN,negative
1052136.0,21 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-10 07:38:00-05:00,QGEN,neutral
1052137.0,"QIAGEN HIghlights Placement Of 2,500th QIAsymphony",2020-01-09 16:12:00-05:00,QGEN,neutral
1052138.0,"Benzinga's Top Upgrades, Downgrades For January 8, 2020",2020-01-08 10:56:00-05:00,QGEN,positive
1052139.0,"Wells Fargo Initiates Coverage On Qiagen with Equal-Weight Rating, Announces $36 Price Target",2020-01-08 09:21:00-05:00,QGEN,positive
1052140.0,"Citigroup Initiates Coverage On Qiagen with Neutral Rating, Announces $35 Price Target",2020-01-07 07:16:00-05:00,QGEN,neutral
1052141.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-06 07:38:00-05:00,QGEN,neutral
1052142.0,34 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-03 07:45:00-05:00,QGEN,neutral
1052143.0,21 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-02 07:49:00-05:00,QGEN,neutral
1052144.0,31 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-12-27 08:13:00-05:00,QGEN,neutral
1052145.0,28 Stocks Moving in Friday's Pre-Market Session,2019-12-27 07:47:00-05:00,QGEN,neutral
1052146.0,60 Biggest Movers From Yesterday,2019-12-27 04:44:00-05:00,QGEN,neutral
1052147.0,"PreMarket Prep Recap: Qiagen Pulls The Rug Out From Investors Banking On A Deal, Bad Data Equals Bad Price Action For Spectrum Pharmaceuticals",2019-12-26 15:57:00-05:00,QGEN,negative
1052148.0,"Mid-Afternoon Market Update: Nasdaq Hits 9,000; Spring Bank Pharmaceuticals Shares Slide",2019-12-26 14:12:00-05:00,QGEN,positive
1052149.0,Qiagen Option Alert: Jan 17 $35 Calls Sweep (2) near the Ask: 1000 @ $1.261 vs 45 OI; Earnings 2/3 After Close [est] Ref=$33.18,2019-12-26 13:45:00-05:00,QGEN,positive
1052150.0,Qiagen Option Alert: Feb 21 $35 Calls at the Ask: 2500 @ $2.201 vs 26 OI; Earnings 2/3 After Close [est] Ref=$33.13,2019-12-26 13:39:00-05:00,QGEN,positive
1052151.0,UPDATE: Several Interested Parties Still In 'Deep Discussions' With Qiagen,2019-12-26 13:14:00-05:00,QGEN,positive
1052152.0,Hearing Qiagen Deal In The Near To Mid-Term Highly Likely,2019-12-26 12:50:00-05:00,QGEN,neutral
1052153.0,34 Stocks Moving In Thursday's Mid-Day Session,2019-12-26 12:11:00-05:00,QGEN,neutral
1052154.0,Mid-Day Market Update: Crude Oil Up 1%; Spectrum Pharmaceuticals Shares Plunge,2019-12-26 12:00:00-05:00,QGEN,negative
1052155.0,Mid-Morning Market Update: Markets Open Higher; Qiagen To Pursue Standalone Business Plan,2019-12-26 10:21:00-05:00,QGEN,neutral
1052156.0,Qiagen shares are trading lower after the company announced it would not be acquired and it will stay a stand-alone business. Bank of America also reinstates its Underperform rating on the stock and announced a price target of $28 per share.,2019-12-26 08:56:00-05:00,QGEN,positive
1052157.0,"The Daily Biotech Pulse: Qiagen Opts To Stay Solo Following Strategic Review, Spectrum Slumps On Negative Data, Microbot Medical To Offer Shares",2019-12-26 07:55:00-05:00,QGEN,negative
1052158.0,18 Stocks Moving in Thursday's Pre-Market Session,2019-12-26 07:35:00-05:00,QGEN,neutral
1052159.0,"Bank of America Reinstates Underperform on Qiagen, Announces $28 Price Target",2019-12-26 06:52:00-05:00,QGEN,neutral
1052160.0,30 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-12-18 08:11:00-05:00,QGEN,neutral
1052161.0,41 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-12-10 08:10:00-05:00,QGEN,neutral
1052162.0,12 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-12-04 07:34:00-05:00,QGEN,neutral
1052163.0,"The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial",2019-12-03 07:59:00-05:00,QGEN,neutral
1052164.0,Stocks That Hit 52-Week Highs On Friday,2019-11-29 10:28:00-05:00,QGEN,neutral
1052165.0,"The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen",2019-11-27 07:26:00-05:00,QGEN,negative
1052166.0,QIAGEN and DiaSorin Receive FDA Approval for The LIAISON QuantiFERON-TB Gold Plus Test on LIAISON Platforms and Begin Commercial Launch,2019-11-27 05:51:00-05:00,QGEN,positive
1052167.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-26 11:03:00-05:00,QGEN,neutral
1052168.0,"The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug",2019-11-26 08:06:00-05:00,QGEN,positive
1052169.0,Stocks That Hit 52-Week Highs On Monday,2019-11-25 10:19:00-05:00,QGEN,neutral
1052170.0,Stocks That Hit 52-Week Highs On Friday,2019-11-22 10:17:00-05:00,QGEN,neutral
1052171.0,19 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-22 07:47:00-05:00,QGEN,neutral
1052172.0,QIAGEN Announces Agreement With LabCorp To Extend QIAGEN Clinical Insights Lincese,2019-11-20 16:10:00-05:00,QGEN,positive
1052173.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,QGEN,neutral
1052174.0,8 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-11-19 07:39:00-05:00,QGEN,neutral
1052175.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,QGEN,neutral
1052176.0,"Benzinga's Top Upgrades, Downgrades For November 18, 2019",2019-11-18 09:48:00-05:00,QGEN,positive
1052177.0,Qiagen shares are trading higher after the company announced it is starting to review all the potential strategic alternatives it received by several conditional and non-binding indications of interest. Commerzbank also upgraded the stock from Hold  to Buy announced a price target of $48 per share.,2019-11-18 08:25:00-05:00,QGEN,positive
1052178.0,5 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-18 07:37:00-05:00,QGEN,neutral
1052179.0,21 Stocks Moving in Monday's Pre-Market Session,2019-11-18 07:19:00-05:00,QGEN,neutral
1052180.0,"Commerzbank Upgrades Qiagen to Buy, Announces $48 Price Target",2019-11-18 07:09:00-05:00,QGEN,neutral
1052181.0,"QIAGEN Shares Resume, Spike 7.8%",2019-11-15 15:41:00-05:00,QGEN,positive
1052182.0,"QIAGEN Reports Receives Several Conditional, Non-Binding Indications Of Interest, Has Entered Talks To Explore Potential Strategic Alternatives",2019-11-15 15:22:00-05:00,QGEN,positive
1052183.0,QIAGEN Shares Halted News Pending,2019-11-15 15:20:00-05:00,QGEN,positive
1052184.0,"Benzinga's Top Upgrades, Downgrades For November 15, 2019",2019-11-15 09:59:00-05:00,QGEN,positive
1052185.0,30 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-15 08:14:00-05:00,QGEN,neutral
1052186.0,"Stifel Nicolaus Initiates Coverage On Qiagen with Hold Rating, Announces $33 Price Target",2019-11-15 06:49:00-05:00,QGEN,neutral
1052187.0,"QIAGEN Shares Up 5% Thurs., Adding On To 10% Rally Wed. Following Bloomberg Report Thermo Fisher Considering Buying Co.",2019-11-14 14:53:00-05:00,QGEN,positive
1052188.0,"JPMorgan Upgrades Qiagen After Product Surveys, Valuation Analysis",2019-11-14 14:14:00-05:00,QGEN,neutral
1052189.0,Qiagen shares are trading higher after JP Morgan upgraded the company's stock from Underweight to Overweight and raised the price target from $25 to $40.,2019-11-14 13:08:00-05:00,QGEN,positive
1052190.0,"Benzinga's Top Upgrades, Downgrades For November 14, 2019",2019-11-14 09:56:00-05:00,QGEN,positive
1052191.0,"JP Morgan Upgrades Qiagen to Overweight, Raises Price Target to $40",2019-11-14 07:57:00-05:00,QGEN,neutral
1052192.0,19 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-11-14 07:35:00-05:00,QGEN,neutral
1052193.0,30 Stocks Moving in Thursday's Pre-Market Session,2019-11-14 07:29:00-05:00,QGEN,neutral
1052194.0,"Qiagen Shares Halted, Up 8.18%",2019-11-13 15:35:00-05:00,QGEN,positive
1052195.0,17 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-11-06 07:52:00-05:00,QGEN,neutral
1052196.0,QIAGEN Launches Novel NGS Workflow for Simultaneous DNA and RNA Analysis for Use in Cancer Profiling at 2019 AMP Annual Meeting,2019-11-06 03:52:00-05:00,QGEN,negative
1052197.0,QIAGEN Reports Initiatives To Expand Its Immuno-Oncology Assets,2019-11-05 16:27:00-05:00,QGEN,positive
1052198.0,17 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-11-01 08:21:00-04:00,QGEN,neutral
1052199.0,"Qiagen N.V. Q3 EPS $0.36 Beats $0.35 Estimate, Sales $382.7M Miss $383.2M Estimate",2019-10-30 17:02:00-04:00,QGEN,negative
1052200.0,8 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-22 07:30:00-04:00,QGEN,neutral
1052201.0,11 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-10-21 07:46:00-04:00,QGEN,neutral
1052202.0,14 Healthcare Stocks Moving In Thursday's Pre-Market Session,2019-10-17 07:42:00-04:00,QGEN,neutral
1052203.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Wed., October 16, 2019",2019-10-16 12:47:00-04:00,QGEN,positive
1052204.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Fri, October 11, 2019",2019-10-11 12:39:00-04:00,QGEN,positive
1052205.0,28 Healthcare Stocks Moving In Friday's Pre-Market Session,2019-10-11 08:42:00-04:00,QGEN,neutral
1052206.0,Qiagen Option Alert: May 15 $30 Calls at the Ask: 1700 @ $2.4 vs 3 OI; Earnings 10/28 After Close [est] Ref=$27.375,2019-10-10 11:02:00-04:00,QGEN,positive
1052207.0,Qiagen Option Alert: May 15 $30 Calls Sweep (4) near the Ask: 2000 @ $2.4 vs 3 OI; Earnings 10/28 After Close [est] Ref=$27.232,2019-10-10 10:37:00-04:00,QGEN,positive
1052208.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Screener Tool For Wed., October 09, 2019",2019-10-09 14:25:00-04:00,QGEN,positive
1052209.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-09 12:55:00-04:00,QGEN,negative
1052210.0,"A Look At Benzinga Pro's Most-Searched Tickers For October 9, 2019",2019-10-09 12:43:00-04:00,QGEN,neutral
1052211.0,Shares of several healthcare companies are trading higher after multiple reports suggesting China is open to a partial trade deal surfaced. The reports renewed optimism in the upcoming U.S.-China trade talks.,2019-10-09 11:10:00-04:00,QGEN,positive
1052212.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday, October 09, 2019",2019-10-09 09:54:00-04:00,QGEN,positive
1052213.0,"Benzinga's Top Upgrades, Downgrades For October 9, 2019",2019-10-09 09:37:00-04:00,QGEN,positive
1052214.0,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug",2019-10-09 07:58:00-04:00,QGEN,negative
1052215.0,13 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2019-10-09 07:54:00-04:00,QGEN,neutral
1052216.0,Kepler Cheuvreux Downgrades Qiagen to Reduce,2019-10-09 06:41:00-04:00,QGEN,neutral
1052217.0,42 Biggest Movers From Yesterday,2019-10-09 05:05:00-04:00,QGEN,neutral
1052218.0,30 Stocks Moving In Tuesday's Mid-Day Session,2019-10-08 12:30:00-04:00,QGEN,neutral
1052219.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-08 12:02:00-04:00,QGEN,negative
1052220.0,Mid-Day Market Update: Qiagen Falls Following Q3 Sales Warning; Asure Software Shares Surge,2019-10-08 12:01:00-04:00,QGEN,negative
1052221.0,"UPDATE: JP Morgan Downgrades Qiagen To Underweight, Lowers Target To $25 As Firm Notes 'Disappointing 3Q Preannounced, While CEO Departure & Slowdown Raise Questions About Execution'",2019-10-08 10:44:00-04:00,QGEN,negative
1052222.0,"Bank of America Maintains Neutral on Qiagen, Lowers Price Target to $33",2019-10-08 10:29:00-04:00,QGEN,negative
1052223.0,Mid-Morning Market Update: Markets Open Lower; Domino's Pizza Earnings Miss Expectations,2019-10-08 10:13:00-04:00,QGEN,negative
1052224.0,"Qiagen Shares Tumble Following Q3 Sales Warning, Sudden CEO Departure",2019-10-08 09:45:00-04:00,QGEN,negative
1052225.0,"Piper Jaffray Maintains Neutral on Qiagen, Lowers Price Target to $31",2019-10-08 09:17:00-04:00,QGEN,negative
1052226.0,9 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-08 08:10:00-04:00,QGEN,neutral
1052227.0,21 Stocks Moving in Tuesday's Pre-Market Session,2019-10-08 07:52:00-04:00,QGEN,neutral
1052228.0,"The Daily Biotech Pulse: D-Day For Clinuvel, Qiagen Warns Of Q3 Shortfall, Prevail Announces Gene Therapy Collaboration",2019-10-08 07:11:00-04:00,QGEN,negative
1052229.0,QIAGEN shares are trading lower after the company said it would suspend ongoing next generation sequence-related instrument development activities,2019-10-08 06:39:00-04:00,QGEN,negative
1052230.0,"JP Morgan Downgrades Qiagen to Underweight, Lowers Price Target to $25",2019-10-08 06:28:00-04:00,QGEN,positive
1052231.0,QIAGEN Announces CEO Leadership Transition,2019-10-07 16:11:00-04:00,QGEN,neutral
1052232.0,"QIAGEN Sees Prelim. Q3 Total Net Sales Growth ~3%, Adj. EPS $0.35-$0.36",2019-10-07 16:10:00-04:00,QGEN,positive
1052233.0,"The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo",2019-10-03 07:34:00-04:00,QGEN,negative
1052234.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-02 10:55:00-04:00,QGEN,negative
1052235.0,"The Daily Biotech Pulse: J&J Settles Ohio Opioid Lawsuit, Teligent Explores Options For Certain Assets, Novartis Reports Cosentyx Data",2019-10-02 07:17:00-04:00,QGEN,positive
1052236.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-01 14:35:00-04:00,QGEN,negative
1052237.0,23 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-10-01 08:24:00-04:00,QGEN,neutral
1052238.0,22 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2019-09-10 09:02:00-04:00,QGEN,neutral
1052239.0,QIAGEN to Integrate its Global Sales Resources into its Business Areas,2019-09-10 04:20:00-04:00,QGEN,neutral
1052240.0,QIAGEN Reports QIAstat-Dx Gastrointestinal Panel Showed Performance In Multicenter Study In Europe,2019-08-14 16:51:00-04:00,QGEN,neutral
1052241.0,"Qiagen Q2 EPS $0.33, Inline, Sales $381.612M Miss $382.88M Estimate",2019-07-30 16:39:00-04:00,QGEN,negative
1052242.0,64 Biggest Movers From Yesterday,2019-07-26 04:36:00-04:00,QGEN,neutral
1052243.0,50 Stocks Moving In Thursday's Mid-Day Session,2019-07-25 13:22:00-04:00,QGEN,neutral
1052244.0,Qiagen shares are trading lower after the company issued preliminary Q2 EPS and sales results.,2019-07-25 11:10:00-04:00,QGEN,neutral
1052245.0,25 Stocks Moving In Thursday's Pre-Market Session,2019-07-25 07:28:00-04:00,QGEN,neutral
1052246.0,"QIAGEN Sees Prelim. Q2 Adj. EPS $0.19, Sales $381.6M",2019-07-24 16:11:00-04:00,QGEN,neutral
1052247.0,Evercore ISI Group Downgrades Qiagen to In-Line,2019-07-16 07:04:00-04:00,QGEN,neutral
1052248.0,QIAGEN And McKesson Agree to Distribute QIAstat-Dx Syndromic Testing Solution To Smaller Hospitals And Other Select Segments In The United States,2019-06-19 16:10:00-04:00,QGEN,positive
1052249.0,QIAGEN's Clinical Insight Selected By National Cancer Center Of Japan's Molecular Oncology Clinical Research And Precision Medicine Initiative,2019-06-18 16:03:00-04:00,QGEN,negative
1052250.0,LabCorp and QIAGEN Announce New therascreen PIK3CA Mutation Analysis Companion Diagnostic For Metastatic Breast Cancer,2019-06-07 16:18:00-04:00,QGEN,negative
1052251.0,QIAGEN and DiaSorin collaborate on novel QuantiFERON-based test with breakthrough potential for earlier detection of Lyme disease,2019-06-05 04:12:00-04:00,QGEN,positive
1052252.0,"Qiagen Snags FDA Nod For Molecular Diagnostic System, Announces US Launch",2019-05-20 10:53:00-04:00,QGEN,neutral
1052253.0,Qiagen NV shares are trading higher after it announced the launch of U.S. launch of its QIAstat-Dx syndromic testing system after it received 510(k) clearance by the F.D.A.,2019-05-20 10:15:00-04:00,QGEN,positive
1052254.0,"The Daily Biotech Pulse: Axovant Doses First Patient In Gene Therapy Trial, Agile Resubmits NDA, ADMA Prices Offering",2019-05-17 08:03:00-04:00,QGEN,neutral
1052255.0,"QIAGEN, Inovio Reports Development Companion Diagnostic For Novel Immunotherapy Targeting Precancerous Cervical Lesions",2019-05-16 16:04:00-04:00,QGEN,positive
1052256.0,Qiagen Reports $100M Buyback,2019-05-06 16:16:00-04:00,QGEN,neutral
1052257.0,"Qiagen Q1 Adj.  EPS $0.27 Beats $0.26 Estimate, Sales $248.7M Miss $350.65M Estimate",2019-05-06 16:15:00-04:00,QGEN,negative
1052258.0,QIAGEN Reports Launch Of Companion Diagnostic Using FGFR Alterations to Help Guide the Treatment of Metastatic Urothelial Cancer,2019-04-12 15:26:00-04:00,QGEN,negative
1052259.0,"QIAGEN's QuantiFERON-TB Passes Milestone Of 60 Million Tests In Global Fight Against Tuberculosis, Current Annual Run Rate Exceeds 12 Million Tests",2019-04-11 16:03:00-04:00,QGEN,negative
1052260.0,"QIAGEN Highlights Expansion Of Content Menu For NeuMoDx 96, 288 Molecular Systems, NeuMoDx 96 Mid-Throughput Version",2019-04-11 16:02:00-04:00,QGEN,neutral
1052261.0,QIAGEN Highlights Profile Of New QIAstat-Dx Meningitis/Encephalitis pAnel Focused On Most Prevalent Central Nervous System Pathogens,2019-04-11 16:00:00-04:00,QGEN,positive
1052262.0,QIAGEN Reports Launch Of Collaboration With LabCorp For Day-1 Access For Patients To Innovative Companion Diagnostics At Time Of Drug Approvals,2019-04-03 16:07:00-04:00,QGEN,positive
1052263.0,QIAGEN Launches Novel Liquid Biopsy Solutions And NGS Panels With Seamlessly Integrated Bioinformatics To Support Advances In Cancer Research,2019-03-28 17:01:00-04:00,QGEN,positive
1052264.0,"The Daily Biotech Pulse: FDA Nod For Novartis, Jazz Positive Late-Stage Data For Sleep Disorder Drug, Genfit IPO",2019-03-27 07:52:00-04:00,QGEN,positive
1052265.0,"The Daily Biotech Pulse: Immutep Gets US Patent, Conatus NASH Disappointment, Eisai Moves On After Aducanumab Setback",2019-03-22 08:16:00-04:00,QGEN,negative
1052266.0,"The Daily Biotech Pulse: Biogen Plummets, FDA Greenlights Sleep Disorder Drug, Cellular Biomedicine Offering",2019-03-21 07:51:00-04:00,QGEN,negative
1052267.0,"Benzinga's Top Upgrades, Downgrades For March 15, 2019",2019-03-15 09:19:00-04:00,QGEN,positive
1052268.0,"UBS Initiates Coverage On Qiagen with Neutral Rating, Announces $42 Price Target",2019-03-15 07:52:00-04:00,QGEN,neutral
1052269.0,"The Daily Biotech Pulse: Horizon Pharma Under DoJ Radar, FDA Greenlights J&J's Depression Drug, Endologix Reverse Split",2019-03-06 07:39:00-05:00,QGEN,negative
1052270.0,QIAGEN Announces Partnership with Ares Genetics in  Fight Against Antibiotic-resistant Pathogens; Financial Details Not Disclosed,2019-02-18 18:44:00-05:00,QGEN,negative
1052271.0,"QIAGEN Sees FY19 Sales Growth 7-8% Year Over Year, Adj. EPS $1.45-$1.47",2019-02-04 16:10:00-05:00,QGEN,positive
1052272.0,"Qiagen NV Q4 EPS $0.40, Inline, Sales $403.2M Miss $408.56M Estimate",2019-02-04 16:10:00-05:00,QGEN,negative
1052273.0,QIAGEN Informatics Solutions Chosen to Support Genomics England's Bold Five Million Genomes in Five Years Project,2019-02-04 04:10:00-05:00,QGEN,positive
1052274.0,"Earnings Scheduled For February 4, 2019",2019-02-04 04:02:00-05:00,QGEN,neutral
1052275.0,QIAGEN Reports Quanti-FERON-TB Gold Plus Gained Approval In Canada,2019-01-14 16:00:00-05:00,QGEN,positive
1052276.0,QIAGEN Acquires N-of-One; Financial Terms Not Disclosed,2019-01-07 03:58:00-05:00,QGEN,neutral
1052277.0,QIAGEN Reports New Collaboration For Development Of Companion Diagnostics From Novartis Drug Candidate,2018-12-06 11:04:00-05:00,QGEN,neutral
1052278.0,QIAGEN And NeoGenomics Announce Master Service Agreement,2018-11-30 16:05:00-05:00,QGEN,positive
1052279.0,QIAGEN Highlights Launch Of QCI INterpret Bioinformatics Features For Use For Blood Cancers As Well As Novel Myeloid Gene Panel For GeneReader NGS System,2018-11-29 16:01:00-05:00,QGEN,positive
1052280.0,"OpGen Collaborates With QIAGEN To Advance Rapid Diagnostics For Antimicrobial Resistant Bacteria; Under Agreement, OpGen Will Purchase EZ1 Instruments And Kits From QIAGEN And Sell Or Place Them In The US",2018-10-31 07:41:00-04:00,QGEN,positive
1052281.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-10-30 08:56:00-04:00,QGEN,neutral
1052282.0,"Qiagen N.V. Q3 EPS $0.35 Beats $0.33 Estimate, Sales $377.9M Miss $381.07M Estimate",2018-10-29 16:52:00-04:00,QGEN,negative
1052283.0,"Earnings Scheduled For October 29, 2018",2018-10-29 04:37:00-04:00,QGEN,neutral
1052284.0,QIAGEN Reports Launch Of Novel RNA-Seq Library Preparation Solutions For Next-Gen Sequencing,2018-10-11 16:20:00-04:00,QGEN,positive
1052285.0,QIAGEN Receives FDA Approval to Expand Use of EGFR Test in Lung Cancer,2018-09-28 03:55:00-04:00,QGEN,neutral
1052286.0,"QIAGEN, NeuMoDx Announce Strategic Partnership to Offer Next-Generation Systems for Fully Integrated Molecular Diagnostic Testing;  QIAGEN Can Acquire All NeuMoDx Shares Not Currently Owned by QIAGEN for ~$234M",2018-09-17 03:40:00-04:00,QGEN,positive
1052287.0,"QIAGEN, DiaSorin Launch Automated Testing for Latent TB infection with QuantiFERON-TB Gold Plus Technology on Widely Used LIAISON Platforms",2018-09-17 03:37:00-04:00,QGEN,neutral
1052288.0,"Stocks Which Set New 52-Week High Yesterday, August 29th",2018-08-30 11:47:00-04:00,QGEN,neutral
1052289.0,"Stocks Which Set New 52-Week High Yesterday, August 28th",2018-08-29 11:13:00-04:00,QGEN,neutral
1052290.0,"The Daily Biotech Pulse: Assertio Settles With Purdue, Emergent Biosolutions In M&A Mix, Novartis Eye Care Unit Recalls Stent",2018-08-29 07:54:00-04:00,QGEN,positive
1052291.0,"HTG Molecular Reports Amended To Statement Of Work Under Master Assay Development, Commercialization, Manufacturing Deal With Qiagen",2018-08-09 08:26:00-04:00,QGEN,neutral
1052292.0,"Stocks Which Set New 52-Week High Yesterday, August 7th",2018-08-08 11:01:00-04:00,QGEN,neutral
1052293.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,QGEN,positive
1052294.0,"Stocks Which Set New 52-Week High Yesterday, August 6th",2018-08-07 11:27:00-04:00,QGEN,neutral
1052295.0,"The Daily Biotech Pulse: FDA Snub For Gemphire, Ligand Earnings, Insmed's Antibiotic Faces FDA Panel",2018-08-07 08:23:00-04:00,QGEN,negative
1052296.0,"Stocks Which Set New 52-Week High Yesterday, August 1st",2018-08-02 10:56:00-04:00,QGEN,neutral
1052297.0,"The Daily Biotech Pulse: Denali's Parkinson's Candidate Clears Early-Stage Trials, Dexcom's Strong Quarter",2018-08-02 08:54:00-04:00,QGEN,positive
1052298.0,60 Stocks Moving In Wednesday's Mid-Day Session,2018-08-01 12:46:00-04:00,QGEN,neutral
1052299.0,30 Stocks Moving In Wednesday's Pre-Market Session,2018-08-01 08:27:00-04:00,QGEN,neutral
1052300.0,QIAGEN Announces careHPV Test Receives WHO Prequalification Status for Cervical Cancer Screening,2018-08-01 03:36:00-04:00,QGEN,negative
1052301.0,QIAGEN Announces Collaboration with Japan's SRL to Accelerate Launch of Companion Diagnostics,2018-08-01 03:31:00-04:00,QGEN,neutral
1052302.0,Qiagen Reaffirms FY18 Outlook,2018-07-31 16:52:00-04:00,QGEN,neutral
1052303.0,"Qiagen Q2 Adj. EPS $0.33 Beats $0.32 Estimate, Sales $377.2M Beat $375.64M Estimate",2018-07-31 16:52:00-04:00,QGEN,neutral
1052304.0,QIAGEN and Hamilton Launch New TB Detection Collaboration To Improve Pre-Analytical Sample Processing For QuantiFERON-TB Gold Plus,2018-07-30 16:47:00-04:00,QGEN,positive
1052305.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings And IPOs",2018-07-28 14:04:00-04:00,QGEN,neutral
1052306.0,QIAGEN Unveils Seamless Next-Gen Sequencing Solutions For Hereditary Diseases On GeneReader NGS System,2018-06-25 16:00:00-04:00,QGEN,positive
1052307.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,QGEN,neutral
1052308.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,QGEN,negative
1052309.0,"Benzinga's Daily Biotech Pulse: vTv Swoons On Failed Alzheimer's Trial, Regenxbio Gets FDA Fast Track For RGX-111",2018-06-13 07:48:00-04:00,QGEN,negative
1052310.0,"Benzinga's Daily Biotech Pulse: Galmed Rips Higher On Positive NASH Data, Enzo Biochem Falls On Earnings, Pfenex Licenses Osteoporosis Candidate",2018-06-12 08:47:00-04:00,QGEN,positive
1052311.0,QIAGEN Welcomes New Guidelines from American Academy of Pediatrics for Detecting Tuberculosis Infection in Children,2018-06-04 04:04:00-04:00,QGEN,positive
1052312.0,Benzinga's Daily Biotech Pulse: Organovo Falls On Earnings; Celgene Gets New CFO,2018-06-01 08:16:00-04:00,QGEN,neutral
1052313.0,"Benzinga's Daily Biotech Pulse: Clinical Hold For Crispr, Gilead Study Meets Endpoint, Akers Gets Grace Time",2018-05-31 08:22:00-04:00,QGEN,positive
1052314.0,"Benzinga's Daily Biotech Pulse: Biomarin Gets FDA Nod, Amarin Settles with Teva, Merck's Cancer Drug Review Extended",2018-05-25 09:19:00-04:00,QGEN,negative
1052315.0,"Qiagen Q1 EPS $0.26 Beats $0.24 Estimate, Sales $343.6M Beat $339.1M Estimate",2018-05-02 16:07:00-04:00,QGEN,neutral
1052316.0,QIAGEN Announces FDA Approval of PartoSure,2018-04-20 03:51:00-04:00,QGEN,positive
1052317.0,QIAGEN Reports European Launch Of QIAstat-Dx,2018-04-19 16:10:00-04:00,QGEN,neutral
1052318.0,QIAGEN Launches AdnaTest Liquid Biopsy Kits For Prostate And Lung Cancer,2018-04-12 16:08:00-04:00,QGEN,negative
1052319.0,"UPDATE: HTG, QIAGEN Amendment Includes 'assay design verification and preparation for regulatory submission' For Next Phase Of Project; QIAGEN To Pay HTG 'low, single-digit millions of dollars in development fees for the Next-Phase Activities'",2018-04-04 17:00:00-04:00,QGEN,negative
1052320.0,HTG Molecular Diagnostics 8-K Shows Co. Entered Second Amendment Of First Statement Of Work With QIAGEN,2018-04-04 16:59:00-04:00,QGEN,neutral
1052321.0,QIAGEN Earlier Announced QuantiFERON-TB® Gold Plus Gained Endorsement For Latent Tuberculosis Screening In Immigration Medical Screenings,2018-03-14 08:38:00-04:00,QGEN,positive
1052322.0,QIAGEN and Natera Partner to Develop Cutting-Edge Genetic Testing Assays,2018-03-12 16:00:00-04:00,QGEN,neutral
1052323.0,QIAGEN Reports QuantiFERON-TB Gold Plus Gained Approval In Japan,2018-02-08 16:32:00-05:00,QGEN,positive
1052324.0,QIAGEN Launches Predictive Therascreen Pitx2 Test in Europe,2018-02-06 16:31:00-05:00,QGEN,neutral
1052325.0,31 Stocks Moving In Thursday's Pre-Market Session,2018-02-01 08:01:00-05:00,QGEN,neutral
1052326.0,"QIAGEN Reports Q4 Adj. EPS $0.43 vs $0.41 Est., Sales $396.9M vs $393.3M Est.",2018-01-31 16:12:00-05:00,QGEN,neutral
1052327.0,QIAGEN Announces $200M Buyback,2018-01-31 16:12:00-05:00,QGEN,neutral
1052328.0,"QIAGEN Reports Deal To Buy STAT-Dx, No Terms Disclosed",2018-01-31 16:11:00-05:00,QGEN,negative
1052329.0,"Goldman Sachs: Qiagen Has 'Strategic Appeal,' M&A Potential",2018-01-29 16:06:00-05:00,QGEN,neutral
1052330.0,"Goldman Sachs Initiates Coverage On Qiagen with Buy Rating, Announces $39.00 Price Target",2018-01-29 09:10:00-05:00,QGEN,neutral
1052331.0,QIAGEN Reports Received FDA Clearance For First-Ever JAK2 Test For Use In Diagnosis Of Added Myeloproliferative Neoplasms,2018-01-23 16:07:00-05:00,QGEN,neutral
1052332.0,QIAGEN Reports Received FDA Approval To Expand Use Of EGFR Test In Lung Cancer,2018-01-18 16:08:00-05:00,QGEN,neutral
1052333.0,"QIAGEN, DiaSorin Partner to Offer Fully Automated Tuberculosis Detection With QuantiFERON-TB Gold Plus Available on LIAISON Analyzer Systems",2018-01-08 03:54:00-05:00,QGEN,neutral
1052334.0,"Evercore ISI Group Initiates Coverage On Qiagen with Outperform Rating, Announces $35.00 Price Target",2018-01-04 08:42:00-05:00,QGEN,neutral
1052335.0,HTG Molecular's Deal With Merck KGaA 'Provides Further Validation' For EdgeSeq Technology,2017-12-27 13:18:00-05:00,QGEN,neutral
1052336.0,"UPDATE: Qiagen Sees Q4 After-Tax charge Of $0.47-$0.52 Per Share, FY18 After-Tax Charge Of $0.03/Share Related To Impairment Of Deferred Assets",2017-12-22 16:17:00-05:00,QGEN,positive
1052337.0,"Qiagen Will Take Impairment On Deferred Tax Assets, Sees Expected Impacts Of New US Tax Law, Other Changes In Global Tax Environment",2017-12-22 16:10:00-05:00,QGEN,positive
1052338.0,"Oxford Immunotec, QIAGEN Report Settlement Of Patent Infringement Suit; All Claims Have Been Resolved; Oxford Has Granted QIAGEN Royalty-Free, Non-Exclusive License To All Current/Future Customers In Exchange For Lump-Sum Payment Of $27.5M",2017-12-15 16:06:00-05:00,QGEN,negative
1052339.0,QIAGEN to Transfer U.S. Listing of Global Shares to NYSE,2017-12-08 16:07:00-05:00,QGEN,positive
1052340.0,"QIAGEN Q3 Adj. EPS $0.32 vs $0.32 Est., Sales $364.0M vs $363.3M Est.",2017-11-07 07:17:00-05:00,QGEN,neutral
1052341.0,HTG Molecular Diagnostics Reports Entered into Second Statement of Work with QIAGEN,2017-11-01 16:48:00-04:00,QGEN,neutral
1052342.0,Qiagen Announces Accuracy Study Results For QIAGEN Clinical Insight,2017-10-19 16:39:00-04:00,QGEN,neutral
1052343.0,"QIAGEN, CENTOGENE Report Collaboration In Bioinformatics For Genetic Diseases",2017-10-09 16:06:00-04:00,QGEN,neutral
1052344.0,"QIAGEN, Clinical Genomics Report Partnership, Implementation PAXgene Blood ccfDNA Tube Sample Collection In CRC Recurrence Assay",2017-08-21 16:06:00-04:00,QGEN,neutral
1052345.0,Independent Research Upgrades Qiagen N.V. - Common Shares to Hold,2017-08-01 05:57:00-04:00,QGEN,positive
1052346.0,Independent Research Upgrades Qiagen to Hold from Sell; Raises PT to €29 from €27,2017-08-01 04:14:00-04:00,QGEN,neutral
1052347.0,"QIAGEN Sees 7% CER Growth For 2017, Keeps Adj. EPS Target Of $1.25-$1.27 CER",2017-07-27 11:20:00-04:00,QGEN,positive
1052348.0,"QIAGEN Reports Q2 Adj. EPS $0.25 vs $0.28 Est., Sales $349M vs $346M Est.",2017-07-27 11:20:00-04:00,QGEN,neutral
1052349.0,HTG Molecular Diagnostics Announces Second Companion Diagnostic Development Project with QIAGEN,2017-07-27 09:18:00-04:00,QGEN,neutral
1052350.0,QIAGEN Reports France's Ministry Of Health And Social Affairs Approved Reimbursement By National Health Insurance System For Co.'s QuantiFERON-TB Gold Plus Screen,2017-06-22 08:09:00-04:00,QGEN,positive
1052351.0,"UPDATE: HTG Says Under SOW With QIAGEN, Co. Expected To Perform Development Work For Initial Phase Of What Is Expected To Become A Multi-Stage Project Leading To Development, Commercialization",2017-06-14 17:39:00-04:00,QGEN,neutral
1052352.0,8-K From HTG Molecular Diagnostics Shows Co. Entered Statement Of Work With QIAGEN Manchester,2017-06-14 17:38:00-04:00,QGEN,neutral
1052353.0,QIAGEN Reports QuantiFERON-TB Gold Plus Gained FDA Approval,2017-06-08 09:11:00-04:00,QGEN,positive
1052354.0,QIAGEN Receives FDA Approval for Cytomegalovirus Testing on Automated QIAsymphony Platform,2017-06-06 04:31:00-04:00,QGEN,positive
1052355.0,QIAGEN Announces License Agreement with Johns Hopkins University for Biomarkers that Play Key Roles in Identifying Patients who could Benefit from Novel I-O Therapies in Cancer Treatment,2017-06-03 15:39:00-04:00,QGEN,positive
1052356.0,"Bristol-Myers Squibb, QIAGEN Sign Agreement for Use of NGS Technology to Develop Gene Expression Profiles for Immuno-Oncology Therapies",2017-06-03 15:36:00-04:00,QGEN,positive
1052357.0,"QIAGEN Reports Q1 Adj. EPS $0.20 vs $0.21 Est., Sales $307.7M vs $306.89M Est.",2017-05-02 16:13:00-04:00,QGEN,neutral
1052358.0,QIAGEN Announces JV With Maccura to Localize and Commercialize GeneReader NGS System in China,2017-05-02 04:05:00-04:00,QGEN,neutral
1052359.0,QIAGEN Offers New Research Suggesting Potential for Added Clinical Utility of Co.'s QuantiFERON-TB Gold Plus,2017-04-12 16:11:00-04:00,QGEN,neutral
1052360.0,QIAGEN Announces Five Independent Studies Validating GeneReader NGS System Gains in Oncology Research,2017-04-03 03:55:00-04:00,QGEN,positive
1052361.0,UPDATE: QIAGEN Says 'Exclusive license to RNA biomarker from The Johns Hopkins University clears path to commercialization',2017-03-31 16:07:00-04:00,QGEN,positive
1052362.0,QIAGEN Reports Expansion of Liquid Biopsy Pipeline with AR-V7 Test in Prostate Cancer,2017-03-31 16:06:00-04:00,QGEN,negative
1052363.0,QIAGEN Announces New Study Published in Lancet Respiratory Medicine Highlights QuantiFERON-TB Potential to Predict Active Tuberculosis Risk in Infants,2017-02-16 03:57:00-05:00,QGEN,positive
1052364.0,"Qiagen Reaffirms FY17 Outlook for 6-7% CER Sales Growth, Adj. EPS $1.25-$1.27 CER",2017-02-01 16:43:00-05:00,QGEN,positive
1052365.0,"QIAGEN Reports Q4 EPS $0.39 vs. Est. $0.34, Rev. $36.5M vs. Est. $370M",2017-02-01 16:15:00-05:00,QGEN,neutral
1052366.0,QIAGEN Reports Details for Completion of Approximately $250 Million Synthetic Share Repurchase,2017-01-18 16:11:00-05:00,QGEN,positive
1052367.0,"Qiagen, Singulex Partner To Have Access To Singulex Single Molecule Counting Immunodiagnostic Platform",2017-01-10 09:06:00-05:00,QGEN,neutral
1052368.0,"QIAGEN Announces Acquisition Of OmicSoft, No Terms Disclosed",2017-01-09 10:18:00-05:00,QGEN,negative
1052369.0,QIAGEN Announces Submission Of QuantiFERON-TB For Pre-Market Approval From FDA,2017-01-09 10:07:00-05:00,QGEN,positive
1052370.0,"Analyst/Investor Days Held Today By Qiagen, Five9, Netgear, 2U, Ultratech",2016-11-15 09:04:00-05:00,QGEN,neutral
1052371.0,20 Biggest Mid-Day Gainers For Thursday,2016-11-03 12:34:00-04:00,QGEN,neutral
1052372.0,"Top Performing Industries For November 3, 2016",2016-11-03 10:46:00-04:00,QGEN,positive
1052373.0,18 Stocks Moving In Thursday's Pre-Market Session,2016-11-03 08:38:00-04:00,QGEN,neutral
1052374.0,Bank of America Upgrades Qiagen N.V. - Common Shares to Neutral,2016-11-03 07:17:00-04:00,QGEN,positive
1052375.0,"QIAGEN Sees FY17 Sales Growth 6-7% CER, Adj. EPS $1.25-$1.27 CER",2016-11-02 16:41:00-04:00,QGEN,positive
1052376.0,"QIAGEN Shares Were Halted Earlier to Announce Q3 Results: Adj. EPS $0.29 vs $0.28 Est., Sales $338.7M vs $338M Est.; Said On Track to Achieve 6-7% CER Sales Growth for FY16",2016-11-02 16:40:00-04:00,QGEN,positive
1052377.0,Qiagen Shares Bounce Off Session Lows; Hearing Sell-Side Firm Has Issued Mid-Morning Upgrade,2016-10-13 09:52:00-04:00,QGEN,positive
1052378.0,"Top Performing Industries For September 30, 2016",2016-09-30 11:13:00-04:00,QGEN,positive
1052379.0,QIAGEN to Return ~$250M to Shareholders Via Synthetic Share Repurchase Proposal,2016-08-14 10:23:00-04:00,QGEN,positive
1052380.0,HSBC Upgrades Qiagen to Buy,2016-08-01 04:24:00-04:00,QGEN,neutral
1052381.0,20 Biggest Mid-Day Gainers For Friday,2016-07-29 13:11:00-04:00,QGEN,neutral
1052382.0,"QIAGEN Reports Q2 Adj. EPS $0.24 vs $0.23 Est., Sales $334.4M vs $326.8M Est.",2016-07-28 16:10:00-04:00,QGEN,neutral
1052383.0,QIAGEN Launches QIAsure Methylation Test to Determine Cervical Cancer Risk,2016-06-14 16:07:00-04:00,QGEN,negative
1052384.0,"QIAGEN Reports Change to Offer Conditions for Exiqon Deal: Acceptance Rate Lowered to 89.2% of Share Capital, Voting Rights",2016-06-08 10:15:00-04:00,QGEN,positive
1052385.0,QIAGEN Launches Liquid Biopsy Workflow for GeneReader NGS System,2016-06-01 16:06:00-04:00,QGEN,neutral
1052386.0,"QIAGEN Reports Extension of Tender Offer Period for Acquisition of Exiqon to Jun. 2, '16",2016-05-19 10:33:00-04:00,QGEN,neutral
1052387.0,"Qiagen Reports Q1 Adj. EPS $0.19, Inline, Sales $298.4M vs $295.8M Est.",2016-04-27 16:15:00-04:00,QGEN,neutral
1052388.0,QIAGEN Launches Streamlined Bioinformatics for RNA Sequencing of Liquid Biopsies,2016-04-14 16:07:00-04:00,QGEN,neutral
1052389.0,"QIAGEN Announces Will Submit Conditional Voluntary Takeover Offer for Shares of Exiqon A/S, No Terms Disclosed",2016-03-29 16:14:00-04:00,QGEN,neutral
1052390.0,QIAGEN Launches Targeted RNA Panels for Next-generation Sequencing,2016-02-11 09:35:00-05:00,QGEN,neutral
1052391.0,"QIAGEN Sees Higher FY16 Adj. Sales, Earnings at CER",2016-02-02 16:07:00-05:00,QGEN,neutral
1052392.0,"QIAGEN Reports Q4 Adj. EPS $0.31 vs $0.32 Est., Sales $349M vs $351.7M Est.",2016-02-02 16:07:00-05:00,QGEN,neutral
1052393.0,QIAGEN to Supply QuantiFERON-TB Tests to Ease Tuberculin Shortage,2016-01-26 04:22:00-05:00,QGEN,positive
1052394.0,Benzinga's Top #PreMarket Losers,2016-01-12 08:27:00-05:00,QGEN,negative
1052395.0,QIAGEN Reaches Milestone With Master Partner Agreements For Pharma Companion Diagnostics,2016-01-11 16:07:00-05:00,QGEN,positive
1052396.0,Mid-Afternoon Market Update: Crude Oil Dips 5.5%; Anavex Shares Spike Higher,2016-01-11 15:12:00-05:00,QGEN,negative
1052397.0,Mid-Day Market Update: US Stocks Turn Lower; Affymetrix Shares Surge On Acquisition News,2016-01-11 12:43:00-05:00,QGEN,neutral
1052398.0,Benzinga's Top #PreMarket Losers,2016-01-11 08:28:00-05:00,QGEN,negative
1052399.0,Why Shares Of Qiagen Plunged Early Monday Morning,2016-01-11 08:14:00-05:00,QGEN,positive
1052400.0,Qiagen Sees Q4 2015 EPS $0.31-$0.32 vs $0.33 Est,2016-01-10 18:27:00-05:00,QGEN,neutral
1052401.0,Qiagen Sees Full-Year 2015 EPS $1.05-$1.06 vs $1.07 Est,2016-01-10 18:26:00-05:00,QGEN,neutral
1052402.0,Benzinga's Top #PreMarket Gainers,2015-12-29 08:15:00-05:00,QGEN,positive
1052403.0,Stifel Nicolaus Initiates Coverage on Qiagen at Hold,2015-11-12 09:38:00-05:00,QGEN,neutral
1052404.0,"Qiagen Reports Q3 Adj. EPS $0.27 vs $0.28 Est., Sales $315M vs $323M Est.",2015-10-28 16:14:00-04:00,QGEN,neutral
1052405.0,Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS,2015-10-19 04:18:00-04:00,QGEN,positive
1052406.0,QIAGEN Reports Launch of New Bioinformatics Solution for Hereditary Diseases,2015-10-05 16:01:00-04:00,QGEN,positive
1052407.0,Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue,2015-09-17 04:23:00-04:00,QGEN,positive
1052408.0,Morgan Stanley: Time To Buy Qiagen,2015-09-15 10:08:00-04:00,QGEN,neutral
1052409.0,"QIAGEN Reports Q2 Sales $319.5M vs $318M Est., Adj. EPS $0.26 vs $0.25 Est.",2015-07-29 16:01:00-04:00,QGEN,neutral
1052410.0,"Top Performing Industries For July 20, 2015",2015-07-20 10:39:00-04:00,QGEN,positive
1052411.0,Benzinga's Top #PreMarket Gainers,2015-07-10 08:12:00-04:00,QGEN,positive
1052412.0,Seegene and QIAGEN Enter Into a Collaboration to Develop Multiplex Molecular Diagnostic Assays,2015-07-08 16:00:00-04:00,QGEN,neutral
1052413.0,Tokai Pharmaceuticals Initiates Phase 3 ARMOR3-SV Trial of Galeterone in AR-V7 Positive Metastatic Castration-Resistant Prostate Cancer,2015-06-24 07:00:00-04:00,QGEN,negative
1052414.0,"QIAGEN, Inova Translational Medicine Institute Introduce New Database of Ethnically and Phenotypically Diverse Whole Genome Information",2015-06-08 16:00:00-04:00,QGEN,neutral
1052415.0,2 Small Cap Pharma Stocks Credit Suisse Loves,2015-05-27 11:10:00-04:00,QGEN,positive
1052416.0,QIAGEN Begins Clinical Bioinformatics Platform for Next-Generation Sequencing,2015-05-26 16:01:00-04:00,QGEN,neutral
1052417.0,"Qiagen Reports Q1 Adj. EPS $0.24 vs $0.22 Est., Sales $298.7M vs $304.6M Est.",2015-05-05 16:01:00-04:00,QGEN,neutral
1052418.0,Top 4 Stocks In The Research Services Industry With The Highest Revenue,2015-04-02 05:45:00-04:00,QGEN,positive
1052419.0,QIAGEN Expands Leadership in Liquid Biopsies with New Circulating Tumor Cell Technology for Development of Companion Diagnostics,2015-03-16 16:06:00-04:00,QGEN,negative
1052420.0,"UBS Initiates Coverage on Qiagen NV at Buy, Announces $28.00 PT",2015-03-10 10:28:00-04:00,QGEN,neutral
1052421.0,Largest-Ever Pivotal Study in China Supports QIAGEN's QuantiFERON,2015-02-11 10:31:00-05:00,QGEN,positive
1052422.0,QIAGEN NV to Launch Voluntary Tender Offer in Respect of Shares of QIAGEN Marseille at €14.90/Share,2015-02-09 05:59:00-05:00,QGEN,positive
1052423.0,QIAGEN Reports Results for Fourth Quarter EPS of $0.25; Full Year EPS of $1/share,2015-01-28 16:05:00-05:00,QGEN,neutral
1052424.0,"Qiagen Sees FY15 Adj. EPS $1.16-$1.18, Sales Growth 4%",2015-01-28 16:05:00-05:00,QGEN,positive
1052425.0,Benzinga's Top #PreMarket Losers,2015-01-23 08:23:00-05:00,QGEN,negative
1052426.0,"Commerzbank Downgrades Qiagen NV to Hold, Lowers PT to $25.00",2015-01-22 06:23:00-05:00,QGEN,negative
1052427.0,Roche Has Granted QIAGEN License Related to EGF Receptor Pathway,2015-01-14 14:03:00-05:00,QGEN,positive
1052428.0,US Stock Futures Signal Higher Start On Wall Street,2015-01-12 07:14:00-05:00,QGEN,neutral
1052429.0,QIAGEN Announces First-ever Regulatory Registration of a Lung Cancer Companion Diagnostic Based on Liquid Biopsies in Collaboration With AstraZeneca,2015-01-12 04:51:00-05:00,QGEN,negative
1052430.0,QIAGEN Announces Offer to Repurchase Existing 2024 Convertible Notes,2015-01-11 16:27:00-05:00,QGEN,neutral
1052431.0,"QIAGEN Reaffirms Guidance for Adjusted Net Sales Growth of ~4% CER for Both the Q4, FY 2014",2015-01-11 16:26:00-05:00,QGEN,positive
1052432.0,QIAGEN Acquires Enzymatics Enzyme Solutions Unit; Financial Terms Not Disclosed,2015-01-11 16:23:00-05:00,QGEN,positive
1052433.0,"QIAGEN Reports Exceeds '14 Goal to Hit 1,250 Cumulative QIAsymphony Placements",2015-01-08 16:01:00-05:00,QGEN,neutral
1052434.0,"Barclays Initiates Coverage On Life Science Tools & Diagnostics, Names Thermo Fisher As 'Top Pick'",2015-01-07 16:41:00-05:00,QGEN,positive
1052435.0,Benzinga's Top #PreMarket Losers,2015-01-06 08:21:00-05:00,QGEN,negative
1052436.0,"JP Morgan Downgrades Qiagen NV to Neutral, Lowers PT to $25.00",2015-01-06 06:39:00-05:00,QGEN,positive
1052437.0,"Goldman Sachs Downgrades Qiagen NV to Sell, Lowers PT to $19.00",2014-12-18 06:07:00-05:00,QGEN,negative
1052438.0,"Qiagen N.V. Reports Q3 EPS of $0.27, Inline; Revenue of $336.80M vs $337.18M Est",2014-10-29 16:08:00-04:00,QGEN,neutral
1052439.0,QIAGEN Announces Broad Agreement With Astellas Pharma to Develop Companion Diagnostics ,2014-10-28 16:01:00-04:00,QGEN,positive
1052440.0,"UPDATE: QIAGEN Reports Expanded Bioinformatics Workflows at ASHG, Highlights Strong Market Adoption",2014-10-17 16:02:00-04:00,QGEN,positive
1052441.0,"QIAGEN Reports Expanded Bioinformatics Workflows at ASHG, Highlights Strong Market Adoption",2014-10-17 16:01:00-04:00,QGEN,positive
1052442.0,Top 4 Stocks In The Research Services Industry With The Highest Profit Margin,2014-08-01 05:16:00-04:00,QGEN,positive
1052443.0,"Qiagen N.V. Reports Q2 EPS of $0.25, Inline; Revenue of $331.20M vs $330.72M Est",2014-07-29 16:14:00-04:00,QGEN,neutral
1052444.0,Qiagen Reports Q2 EPS of $0.26,2014-07-29 16:01:00-04:00,QGEN,neutral
1052445.0,QIAGEN Announces Collaboration Agreement with AstraZeneca to Develop Liquid Biopsy-based Companion Diagnostic,2014-07-28 05:33:00-04:00,QGEN,positive
1052446.0,Top 4 NASDAQ Stocks In The Research Services Industry With The Highest EPS,2014-07-18 04:36:00-04:00,QGEN,positive
1052447.0,Wells Fargo Initiates Coverage on Qiagen N.V. at Market Perform,2014-07-10 06:41:00-04:00,QGEN,positive
1052448.0,US Stock Futures Edge Lower Ahead Of Consumer Spending Report,2014-05-30 07:21:00-04:00,QGEN,negative
1052449.0,QIAGEN Announces Collaboration with Lilly,2014-05-30 05:31:00-04:00,QGEN,neutral
1052450.0,UPDATE: HSBC Upgrades Qiagen N.V. to Neutral,2014-05-13 10:53:00-04:00,QGEN,neutral
1052451.0,Benzinga's Top Upgrades,2014-05-13 07:53:00-04:00,QGEN,positive
1052452.0,"HSBC Upgrades Qiagen N.V. to Neutral, Raises PT to $23.33",2014-05-13 06:24:00-04:00,QGEN,neutral
1052453.0,"Qiagen N.V. Reports Q1 EPS of $0.22, Inline; Revenue of $317.40M vs $316.94M Est; Announces $100M Buyback Plan",2014-05-06 16:13:00-04:00,QGEN,neutral
1052454.0,Top 4 NASDAQ Stocks In The Research Services Industry With The Highest Revenue,2014-04-23 04:31:00-04:00,QGEN,positive
1052455.0,Top 4 Stocks In The Research Services Industry With The Lowest PEG Ratio,2014-03-27 04:30:00-04:00,QGEN,negative
1052456.0,Berenberg Upgrades Qiagen N.V. to Buy,2014-03-18 07:45:00-04:00,QGEN,neutral
1052457.0,Qiagen N.V. Sees FY2014 EPS $1.07-1.09 vs $1.14 Est,2014-01-29 16:11:00-05:00,QGEN,neutral
1052458.0,Qiagen N.V. Sees Q1 EPS $0.21-0.22 vs $0.24 Est,2014-01-29 16:11:00-05:00,QGEN,neutral
1052459.0,Qiagen N.V. Reports Q4 EPS of $0.36 vs $0.33 Est; Revenue of $362.60M vs $365.48M Est,2014-01-29 16:11:00-05:00,QGEN,neutral
1052460.0,QIAGEN Announces European Launch of Therascreen IDH1/2Test for Gliomas  ,2014-01-06 16:49:00-05:00,QGEN,neutral
1052461.0,UPDATE: JMP Securities Initiates Coverage on Qiagen NV on Multiple Positive Factors,2013-12-18 10:19:00-05:00,QGEN,positive
1052462.0,"JMP Securities Initiates Coverage on Qiagen N.V. at Market Outperform, Announces $30.00 PT",2013-12-18 07:08:00-05:00,QGEN,positive
1052463.0,Qiagen Says Will Buyback Up to $45M in Shares by Mar. 14th,2013-12-17 12:19:00-05:00,QGEN,positive
1052464.0,Benzinga's Top #PreMarket Losers,2013-11-25 08:20:00-05:00,QGEN,negative
1052465.0,Benzinga's Top Upgrades,2013-11-19 07:59:00-05:00,QGEN,positive
1052466.0,"Citigroup Upgrades Qiagen N.V. to Neutral, Raises PT to $24.00",2013-11-19 07:16:00-05:00,QGEN,neutral
1052467.0,Benzinga's Top #PreMarket Losers,2013-11-18 08:16:00-05:00,QGEN,negative
1052468.0,QIAGEN Announces Agreement to Develop Molecular Companion Diagnostic Paired with Lilly Investigational Cancer Compounds ,2013-11-18 08:09:00-05:00,QGEN,negative
1052469.0,"Cowen & Company Upgrades Qiagen N.V. to Market Perform, Raises PT to $21.00",2013-10-31 09:05:00-04:00,QGEN,neutral
1052470.0,QIAGEN Announces Partnership With Clovis Oncology to Co-develop Companion Diagnostic Targeting Drug-Resistant EGFR Mutations,2013-10-21 16:02:00-04:00,QGEN,neutral
1052471.0,"UBS Removed Qigen from 'Most Preferred' List, Maintains Neutral",2013-10-14 06:53:00-04:00,QGEN,neutral
1052472.0,Disappointing Preliminary Earnings from Quest Diagnostics Trickles Down to Qiagen,2013-10-10 14:23:00-04:00,QGEN,negative
1052473.0,Exane Downgrades Qiagen N.V. to Underperform,2013-10-04 08:40:00-04:00,QGEN,neutral
1052474.0,UBS Adds Qiagen to 'Most Preferred' List,2013-09-17 08:37:00-04:00,QGEN,neutral
1052475.0,Morgan Stanley Initiates Coverage on Qiagen N.V. at Equalweight,2013-09-06 08:44:00-04:00,QGEN,neutral
1052476.0,"Janney Capital Initiates Coverage on Qiagen N.V. at Neutral, Announces $24.00 PT",2013-08-15 08:46:00-04:00,QGEN,neutral
1052477.0,Qiagen N.V. Reports Q2 EPS of $0.27 vs $0.23 Est,2013-07-30 16:06:00-04:00,QGEN,neutral
1052478.0,QIAGEN Receives FDA Approval for therascreen® EGFR RGQ PCR Kit as a Companion Diagnostic for Lung Cancer Patients ,2013-07-12 10:25:00-04:00,QGEN,negative
1052479.0,FDA Issues Report for June 13th Panel Meeting on Flu Tests,2013-06-11 12:03:00-04:00,QGEN,negative
1052480.0,"Barclays Downgrades Qiagen N.V. to Equalweight, Lowers PT to $19.00",2013-05-01 09:13:00-04:00,QGEN,negative
1052481.0,Qiagen N.V. Sees Q2 EPS $0.25 vs $0.26 Est,2013-04-29 16:12:00-04:00,QGEN,neutral
1052482.0,Qiagen N.V. Reports Q1 EPS of $0.23 vs $0.22 Est; Revenue of $303.60M vs $305.50M Est,2013-04-29 16:05:00-04:00,QGEN,neutral
1052483.0,QIAGEN Acquires Ingenuity Systems,2013-04-29 16:02:00-04:00,QGEN,neutral
1052484.0,"Citigroup Initiates Coverage on Qiagen N.V. at Sell, Announces $18.00 PT",2013-04-18 06:31:00-04:00,QGEN,neutral
1052485.0,Benzinga's Top Pre-Market Losers,2013-03-04 08:24:00-05:00,QGEN,negative
1052486.0,"Jefferies Maintains Hold on Qiagen N.V., Raises PT to $19.00",2013-01-31 07:54:00-05:00,QGEN,neutral
1052487.0,Stocks Hitting 52-Week Highs,2013-01-30 10:26:00-05:00,QGEN,neutral
1052488.0,"Qiagen Q4 Adj. EPS $0.34, Sales $346.5M; FY12 Sales $1.25B; Sees FY13 Adj. EPS $1.16-1.18",2013-01-29 16:05:00-05:00,QGEN,neutral
1052489.0,Cowen & Company Downgrades Qiagen N.V. to Underperform,2013-01-14 08:31:00-05:00,QGEN,neutral
1052490.0,IMDx Enters into an Agreement with QIAGEN to Develop Molecular Tests,2013-01-07 16:02:00-05:00,QGEN,positive
1052491.0,From Earlier: Qiagen Gains SFDA Approval to Market careHPV Test in China,2012-11-28 16:59:00-05:00,QGEN,positive
1052492.0,"Earnings Scheduled For October 29, 2012",2012-10-29 07:01:00-04:00,QGEN,neutral
1052493.0,Top 4 Stocks In The Research Services Industry With The Highest Cash,2012-07-25 04:49:00-04:00,QGEN,positive
1052494.0,Qiagen Reports Q2 EPS $0.25 vs $0.23 Est; Revenues $307.2M vs $303.54M Est,2012-07-24 16:07:00-04:00,QGEN,neutral
1052495.0,"Barclays Maintains Qiagen at Overweight, Raises PT from $17 to $18",2012-07-23 12:35:00-04:00,QGEN,negative
1052496.0,"UPDATE: ISI Group Initiates Qiagen with Underweight, $15 PT on Muted BioPharma and Academic Segments  ",2012-07-10 10:16:00-04:00,QGEN,neutral
1052497.0,"UPDATE: Goldman Sachs Upgrades Qiagen NV to Neutral on M&A Outlook, HPV Visibility  ",2012-07-02 11:29:00-04:00,QGEN,neutral
1052498.0,Goldman Sachs Upgrades Qiagen from Sell to Neutral,2012-07-02 08:21:00-04:00,QGEN,neutral
1052499.0,Qiagen Acquires Intelligent Bio-Systems,2012-06-25 16:48:00-04:00,QGEN,positive
1052500.0,QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics ,2012-06-25 16:01:00-04:00,QGEN,positive
1052501.0,Societe Generale Discontinues Coverage on Qiagen,2012-06-22 13:46:00-04:00,QGEN,neutral
1052502.0,Qiagen Reports Q1 EPS $0.23 vs $0.2 Est; Revenues $296.4M vs $285.06M Est,2012-04-25 16:14:00-04:00,QGEN,neutral
1052503.0,From Earlier: QIAGEN Receives FDA Clearances for Rotor-Gene Q MDx Instrument and Compatible Influenza A/B Assay  ,2012-04-17 08:13:00-04:00,QGEN,neutral
1052504.0,Quarterly Changes to the NASDAQ Q-50 Index ,2012-03-12 08:41:00-04:00,QGEN,neutral
1052505.0,Qiagen Reports Q4 EPS $0.31 vs $0.27 Est; Revenues $334.40M vs $322.76M Est	 			,2012-01-31 16:04:00-05:00,QGEN,neutral
1052506.0,UPDATE: JP Morgan Upgrades Qiagen to Overweight,2012-01-04 10:38:00-05:00,QGEN,neutral
1052507.0,Benzinga's Top Pre-Market Gainers,2012-01-04 08:06:00-05:00,QGEN,positive
1052508.0,JP Morgan Upgrades Qiagen to Overweight,2012-01-04 06:51:00-05:00,QGEN,neutral
1052509.0,Qiagen Launches Project to Improve Efficiency; Cutting 8-10% of Jobs; No Change to 2011 Outlook; Will Free Up Resources to Drive Growth; Sees PreTax $20M 2012 Restructuring Charge,2011-11-28 17:03:00-05:00,QGEN,positive
1052510.0,Benzinga's Top Pre-Market Gainers,2011-11-03 08:09:00-04:00,QGEN,positive
1052511.0,Qiagen Sees 2011 EPS $0.96-$0.97 vs $0.89 Est,2011-11-02 16:46:00-04:00,QGEN,neutral
1052512.0,Qiagen NV Reports Q3 EPS $0.24 vs $0.21 Est; Sales $288.9M vs $290.25M Est			,2011-11-02 16:43:00-04:00,QGEN,neutral
1052513.0,Top 4 Stocks In The Research Services Industry With The Highest Operating Margin,2011-11-01 04:09:00-04:00,QGEN,positive
1052514.0,Hearing RBC Saying That Abbott Expected to Acquire Qiagen After Split,2011-10-19 12:31:00-04:00,QGEN,neutral
1052515.0,"End-of-Day Market Summary for October 18, 2011",2011-10-18 16:15:00-04:00,QGEN,neutral
1052516.0,"Piper Jaffray Downgrades Qiagen NV to Neutral, PT Lowered to $12",2011-10-18 09:36:00-04:00,QGEN,negative
1052517.0,A Peek Into The Market Before The Trading Starts,2011-08-16 07:30:00-04:00,QGEN,neutral
1052518.0,QIAGEN and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer  ,2011-08-16 06:53:00-04:00,QGEN,negative
1052519.0,A Peek Into The Market Before The Trading Starts,2011-08-08 07:27:00-04:00,QGEN,neutral
1052520.0,A Peek Into The Market Before The Trading Starts,2011-08-05 07:27:00-04:00,QGEN,neutral
1052521.0,QIAGEN Completes Second U.S.Submission for Companion Diagnostic to Guide Treatment Decisions in Colorectal Cancer ,2011-08-05 06:56:00-04:00,QGEN,negative
1052522.0,Stocks to Watch for Wednesday 8/03/2011: Fresh 52 Week Highs and Lows,2011-08-03 01:05:00-04:00,QGEN,positive
1052523.0,Stocks to Watch for Tuesday 8/02/2011: Fresh 52-Week Highs and Lows,2011-08-02 04:20:00-04:00,QGEN,positive
1052524.0,Piper Jaffray Rates QGEN,2011-07-27 08:28:00-04:00,QGEN,neutral
1052525.0,Qiagen N.V  Reports EPS of $0.23 vs. $0.22 EST; Revenues $282M vs. $ 280.30M EST ,2011-07-25 16:59:00-04:00,QGEN,neutral
1052526.0,Wedbush Downgrades Qiagon from Outperform to Neutral and Lowers PT from $24 to $19,2011-07-25 08:15:00-04:00,QGEN,negative
1052527.0,Benzinga's Top Pre-Market NASDAQ Losers,2011-06-23 08:13:00-04:00,QGEN,negative
1052528.0,Relative Put Volume Surges on QIAGEN N.V. (QGEN),2011-05-05 12:30:00-04:00,QGEN,neutral
1052529.0,"TOP 15 Stocks To Watch this week- AAPL, BRK-A, BRK-B, BJ, C, F, GM, GPRO, IP, KND, N, NRTLQ, ONTY, SPPI, YRCW",2011-05-02 04:48:00-04:00,QGEN,positive
1052530.0,"Rwanda, Merck and QIAGEN Launch Africa's First Comprehensive Cervical Cancer Prevention Program Incorporating Both HPV Vaccination and HPV Testing   ",2011-04-25 08:35:00-04:00,QGEN,negative
1052531.0,Goldman Opens QGEN With Sell,2011-02-23 06:39:00-05:00,QGEN,neutral
1052532.0,Societe Generale Ups QGEN To Buy,2011-02-03 05:54:00-05:00,QGEN,neutral
1052533.0,"Qiagen Outpaces EPS Est, Revenues Lag - Analyst Blog",2011-02-01 12:31:00-05:00,QGEN,negative
1052534.0,"Qiagen Outpaces EPS Est, Revenues Lag - Analyst Blog",2011-02-01 12:15:00-05:00,QGEN,negative
1052535.0,QIAGEN Reports Q4 EPS of $.26 vs. $.25,2011-01-31 16:19:00-05:00,QGEN,neutral
1052536.0,Exane BNP Paribas Downs QGEN To Neutral,2011-01-19 06:23:00-05:00,QGEN,neutral
1052537.0,Piper Jaffray's Top Picks For Medical Diagnostics,2011-01-14 08:47:00-05:00,QGEN,positive
1052538.0,Piper Jaffray Introduces 2012 Estimates On QGEN,2010-12-30 08:03:00-05:00,QGEN,neutral
1052539.0,"Benzinga's Top Pre-Market NASDAQ Losers (CRDC, GPIC, VRSN, QGEN)",2010-12-16 09:03:00-05:00,QGEN,negative
1052540.0,"Benzinga's Top Downgrades (IRET, AEG, QGEN, RTN)",2010-12-16 08:21:00-05:00,QGEN,positive
1052541.0,Jefferies Downgrades Qiagen To Hold,2010-12-16 08:06:00-05:00,QGEN,neutral
1052542.0,RBC Capital Decreases Qiagen PT To $18,2010-11-15 10:16:00-05:00,QGEN,neutral
1052543.0,"Benzinga's Top Upgrades (GOV, QGEN, AH, GMET)",2010-11-12 07:57:00-05:00,QGEN,positive
1052544.0,Piper Jaffray Upgrades QGEN To Overweight,2010-11-12 06:50:00-05:00,QGEN,negative
1052545.0,Qiagen Beats but Cuts Rev Guidance - Analyst Blog,2010-11-10 09:30:00-05:00,QGEN,negative
1052546.0,"Benzinga's Top Pre-Market NASDAQ Losers (SNTS, CSKI, CHBT, QGEN)",2010-11-09 08:36:00-05:00,QGEN,negative
1052547.0,"Earnings Scheduled For November 8 (FTR, LDK, PCLN, SYY, CCO, MDR, QGEN, APEI)",2010-11-08 03:31:00-05:00,QGEN,neutral
1052548.0,"Benzinga's Top Pre-Market NASDAQ Gainers (CSCX, ACLS, TSPT, QGEN)",2010-10-19 08:24:00-04:00,QGEN,positive
1052549.0,Qiagen Inks Deal with Abbott  - Analyst Blog,2010-10-18 11:03:00-04:00,QGEN,neutral
1052550.0,"Benzinga’s Top Pre-Market NASDAQ Gainers (TTWO, FNSR, ULTA, QGEN)",2010-09-03 08:44:00-04:00,QGEN,positive
1052551.0,Hologic Stays Neutral  - Analyst Blog,2010-08-19 12:04:00-04:00,QGEN,neutral
1052552.0,"Benzinga’s Top Pre-Market NASDAQ Losers (MNKD, MAIN, NVAX, QGEN)",2010-08-17 08:36:00-04:00,QGEN,negative
1052553.0,Qiagen Beats by a Whisker - Analyst Blog,2010-08-11 04:07:00-04:00,QGEN,neutral
1052554.0,"Benzinga’s Top Pre-Market NASDAQ Losers (NUAN, CPLP, FEED, QGEN)",2010-08-10 09:08:00-04:00,QGEN,negative
1052555.0,Earnings Scheduled For August 09,2010-08-09 05:20:00-04:00,QGEN,neutral
1052556.0,"Benzinga’s Top Upgrades (CHSI, H, INWK, QGEN)",2010-08-06 06:57:00-04:00,QGEN,positive
1052557.0,"Benzinga’s Top Pre-Market NASDAQ Losers (QGEN, ERIC, ASML, AMZN)",2010-07-26 08:37:00-04:00,QGEN,negative
1052558.0,"Benzinga’s Volume Movers (QGEN, RIMM, COCO, ARBA, GOOG)",2010-07-09 14:24:00-04:00,QGEN,neutral
1052559.0,"Benzinga’s Top Pre-Market Gainers (NANO, GOOG, BANR, QGEN)",2010-07-09 09:08:00-04:00,QGEN,positive
1052560.0,"Benzinga’s Top Pre-Market Gainers (ENER, RJET, NLST, QGEN)",2010-07-08 09:16:00-04:00,QGEN,positive
1052561.0,Playing Food Safety with Qiagen ,2010-07-01 14:28:00-04:00,QGEN,positive
1052562.0,"Benzinga’s Top Pre-Market Gainers (GERN, MSPD, ENG, QGEN, ASML)",2010-05-19 10:00:00-04:00,QGEN,positive
1052563.0,"Benzinga’s Top Pre-Market Losers (LINE, QGEN, DNDN, VOD)",2010-03-23 08:32:00-04:00,QGEN,negative
1052564.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,QGEN,positive
1052565.0,"Benzinga’s Top Pre-Market Losers (ACAS, TRMD, JASO, ENDP, AIXG, QGEN)",2010-01-19 09:06:00-05:00,QGEN,negative
1052566.0,"Benzinga’s Top Pre- Market Losers (CBAK, JASO, JNJ, QGEN, ACAS, MPEL, EGLE)",2009-12-30 08:36:00-05:00,QGEN,negative
1052567.0,New Additions To The Nasdaq 100 Index,2009-12-14 00:56:00-05:00,QGEN,neutral
1052568.0,"Benzinga’s Top Pre- Market Gainers (TIF, RFMD, AIXG, INCY, SOLF, QGEN, CYTX, SVA)",2009-11-25 08:40:00-05:00,QGEN,positive
1052569.0,"WallStSense.com Fundamental & Technical Coverage of MYGN, JRCC, QGEN, QLGC, MDRX and OVTI",2009-08-18 06:29:00-04:00,QGEN,neutral
